[Hepatitis C] (Q72749710)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

review article

1 reference

title

[Hepatitis C] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

author name string

P Giral

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

L Serfaty

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

A Loria

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

R Poupon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

Revue de Médecine Interne

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

487-493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Descartes before the Horse: I Clone, Therefore I Am: The Hepatitis C Virus in Current Perspective

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Antibodies to hepatitis C virus in French blood donors

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Detection of HCV RNA and antibodies to HCV after needlestick injury

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

HCV in saliva of chronic hepatitis patients having dental treatment

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Failure to detect vertical transmission of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Mother-to-infant transmission of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Vertical transmission of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Persistent hepatitis C viraemia without liver disease

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Hepatitis C-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Reliability of polymerase chain reaction for detection of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

The pathology of hepatitis C

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Hepatitis B and C viral infections in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

A role for hepatitis C virus infection in type II cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Mixed cryoglobulinemia responsive to interferon-alpha

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Interferon for non-A, non-B chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016/S0248-8663(05)81475-4

7 January 2021

10.1016/S0248-8663(05)81475-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7938962 AND SRC:MED&resulttype=core&format=json

28 October 2019

1 reference